Valo DSV - Actualités
CEA
Tuesday 23 April 2013
Theranexus: boosting the effectiveness of psychotropics
CEA The start-up Theranexus, a spin-off from the CEA, was launched on March 19. Its objective: to propose an adjuvant treatment [1] to be given in addition to psychotropic [2] medications that will augment their effectiveness or, in diminished doses, reduce their undesirable effects. Theranexus will be engaged in a large part of the product chain, from preclinical research to phase 2 clinical trials.
En savoir plus
Theranexus: boosting the effectiveness of psychotropics
CEA The start-up Theranexus, a spin-off from the CEA, was launched on March 19. Its objective: to propose an adjuvant treatment [1] to be given in addition to psychotropic [2] medications that will augment their effectiveness or, in diminished doses, reduce their undesirable effects. Theranexus will be engaged in a large part of the product chain, from preclinical research to phase 2 clinical trials.
En savoir plus
CEA
Monday 21 January 2013
Creation of the “Integrated Structural Biology, Grenoble (ISBG)” mixed research institute
The Unité Mixte de Service (mixed research institute) UMS 3518 (CNRS-CEA-UJF-EMBL) was created on January 1st 2013, in Grenoble. This new unit brings together facilities from the IBS and UVHCI, and represents an impressive collection of state-of-the-art equipment for integrated structural biology. The unit is open to national and international scientific communities, as well as industry.
En savoir plus
Creation of the “Integrated Structural Biology, Grenoble (ISBG)” mixed research institute
The Unité Mixte de Service (mixed research institute) UMS 3518 (CNRS-CEA-UJF-EMBL) was created on January 1st 2013, in Grenoble. This new unit brings together facilities from the IBS and UVHCI, and represents an impressive collection of state-of-the-art equipment for integrated structural biology. The unit is open to national and international scientific communities, as well as industry.
En savoir plus